Press release
Corporate Press
December 20, 2011

Evonik plans to build a new production plant for cosmetic ingredients in Brazil

  • Production capacity of over 25,000 metric tons p.a.
  • Start-up scheduled for early 2014

Evonik is pressing ahead with the planning phase for a new production facility for a wide range of ingredients for cosmetics and consumer goods in Americana in the Brazilian state of São Paulo. The planned investment is in the mid-double-digit million euro range. Production capacity will exceed 25,000 metric tons p.a. and start-up is scheduled for early 2014. The project is contingent upon the approval of the internal boards.

"The aim of this project is to establish production in Americana to improve our ability to serve the market in Brazil and South America," explains Patrik Wohlhauser, the member of the Evonik's Executive Board responsible for the Consumer, Health & Nutrition segment and the South America region.

Evonik already supplies customers in this region through its service and logistics center in Guarulhos (Brazil). The company also plans to step up these activities in the future.

"A production facility in Brazil would expand our global production network for the consumer goods industry and give Evonik access to South America, which is an attractive growth market," comments Dr. Claus Rettig, who heads up the Consumer Specialties Business Unit.

Evonik has production facilities for cosmetic ingredients in Europe, the USA and Asia. In addition to this project, at the end of March 2011 Evonik announced that it would be building a further production plant for ingredients for cosmetics and household consumer goods in Shanghai (China) to serve the Asian market. This facility is scheduled to come on stream in about two years and involves investment in the upper double-digit million euro range.

About Evonik

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.